Optimizing Outcomes With Oral Antiplatelet Therapies

Optimizing Outcomes With Oral Antiplatelet Therapies
Optimizing Outcomes With Oral Antiplatelet Therapies

PROGRAM DESCRIPTION

In this interactive presentation, Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC, reviews current guidelines and emerging data on selecting oral antiplatelet therapies, including the optimal duration of dual antiplatelet therapy in selected patients.

INTENDED AUDIENCE

This activity is intended for cardiologists, hospitalists, and other clinicians caring for patients who require antiplatelet therapy for secondary prevention of acute coronary syndromes and/or other thrombotic conditions.

EDUCATIONAL OBJECTIVES

Upon completion of this activity, participants should be able to:

  • Apply guideline-based approaches to antiplatelet therapy for patients who are post acute coronary syndrome
  • Analyze the risks and benefits of shorter duration of dual antiplatelet therapy in patients post percutaneous coronary intervention
  • Identify individual patient characteristics that may influence success of dual antiplatelet therapy, such as comorbidities
To take the course, click here or go to mycme.com.

This course expires Oct. 1, 2016.

Don't miss any McKnight's news